parthenolide has been researched along with indocyanine green in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, C; Gao, D; Gao, W; He, Y; Li, L; Luo, L; Zhang, X | 1 |
| Jin, X; Lu, X; Lv, H; Zhang, Z | 1 |
2 other study(ies) available for parthenolide and indocyanine green
| Article | Year |
|---|---|
Nanomagnetic liposome-encapsulated parthenolide and indocyanine green for targeting and chemo-photothermal antitumor therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Ferric Compounds; Indocyanine Green; Liposomes; Metal Nanoparticles; Photochemotherapy; Phototherapy; Sesquiterpenes | 2020 |
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrodynamics; Indocyanine Green; Liposomes; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Photosensitizing Agents; Reactive Oxygen Species; Sesquiterpenes; Temperature; Tissue Distribution; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2020 |